N. R. Santos

Prevalence and risk factors for long COVID after mild disease: a longitudinal study with a symptomatic control group.

A. Barral, R. Khouri, V. Boaventura, 2022, medRxiv.

Antiphospholipid syndrome plus rheumatic fever: a higher risk factor for stroke?

R. Pereira, L. Mota, J. Carvalho, 2012, Rheumatology International.

Distinct antibody profile: a clue to primary antiphospholipid syndrome evolving into systemic lupus erythematosus?

E. Bonfá, J. Carvalho, C. Bueno, 2014, Clinical Rheumatology.